Nasdaq Biotechnology
Index
RETURN
Abgenix
Inc.
Affymetrix
Inc.
Albany
Molecular Research, Inc.
Alexion
Pharmaceuticals, Inc.
Alkermes,
Inc.
Amgen
Inc.
Amylin
Pharmaceuticals, Inc.
Antigenics
Inc.
Arena
Pharmaceuticals, Inc.
ArQule,
Inc.
Array
BioPharma Inc.
Atrix
Laboratories, Inc.
Avigen,
Inc.
Biogen,
Inc.
BioMarin
Pharmaceutical Inc.
Caliper
Technologies Corp.
Celgene
Corporation
Cell
Genesys, Inc.
Cell
Therapeutics, Inc.
Cephalon,
Inc.
Chiron
Corporation
Corixa
Corporation
Cubist
Pharmaceuticals, Inc.
CuraGen
Corporation
CV
Therapeutics, Inc.
Diversa
Corporation
Emisphere
Technologies, Inc.
EntreMed,
Inc.
Enzon,
Inc.
Exelixis,
Inc.
Gene
Logic Inc.
Genta
Incorporated
Genzyme
General
Geron
Corporation
Gilead
Sciences, Inc.
Guilford
Pharmaceuticals Inc.
Human
Genome Sciences, Inc.
ICOS
Corporation
IDEC
Pharmaceuticals Corporation
ILEX
Oncology, Inc.
ImClone
Systems Incorporated
Immunex
Corporation
ImmunoGen,
Inc.
Immunomedics,
Inc.
Incyte
Genomics Inc.
Inhale
Therapeutic Systems, Inc.
InterMune,
Inc.
Invitrogen
Corporation
Isis
Pharmaceuticals, Inc.
Ligand
Pharmaceuticals Incorporated
Luminex
Corporation
Medarex,
Inc.
Medicines
Company (The)
MedImmune,
Inc.
Millennium
Pharmaceuticals, Inc.
Myriad
Genetics, Inc.
NeoPharm,
Inc.
Neurocrine
Biosciences, Inc.
Novavax,
Inc.
NPS
Pharmaceuticals, Inc.
OSI
Pharmaceuticals Inc.
Pharmacopeia,
Inc.
Protein
Design Labs, Inc.
Qiagen
N.V.
QLT
Inc.
Regeneron
Pharmaceuticals, Inc.
Scios,
Inc.
Tanox,
Inc.
Telik,
Inc.
Transkaryotic
Therapies, Inc.
Trimeris,
Inc.
Tularik
Inc.
United
Therapeutics Corporation
VaxGen,
Inc.
Vertex
Pharmaceuticals Incorporated
ViroPharma
Incorporated
|